In the UK, weight loss injections have become a popular method for managing obesity, especially for those who struggle with weight loss through diet and exercise alone. These injections typically include medications such as liraglutide (sold under the brand name Saxenda), semaglutide (sold as Wegovy or Ozempic), and others like them. They work by mimicking hormones that target areas of the brain involved in appetite regulation, which helps reduce hunger and calorie intake.
These medications are usually prescribed as part of a comprehensive weight management plan that includes diet, exercise, and regular consultations with healthcare professionals. It’s important to note that these injections are generally prescribed for individuals who meet specific medical criteria, such as having a body mass index (BMI) of 30 or higher, or 27 or higher with weight-related health conditions like type 2 diabetes, high blood pressure, or high cholesterol.
The effectiveness of these injections varies from person to person, but many users report significant weight loss. However, they can have side effects, which might include nausea, vomiting, diarrhea, constipation, and potential injection site reactions. It’s crucial for anyone considering these treatments to consult with healthcare providers to understand the risks and benefits.
These treatments are available in the UK both through the NHS (where eligible) and private healthcare providers, but the criteria for NHS provision are strict, often requiring participants to be part of weight management programs.
